Enjoy FREE SHIPPING on all FreeStyle Libre 2 purchases until 31 May 2024. Simply enter promo code FREESHIP at checkout and click ‘SUBMIT CODE’ to apply!
Pharmac proposes to commence FreeStyle Libre 2 subsidy for people living with type 1 diabetes! Read more
Menu
X
In exciting news, from 1 July 2024 – Pharmac proposes to commence FreeStyle Libre 2 subsidy for all people living with type 1 diabetes in New Zealand!
On 11 July 2023, Pharmac released a Request for Proposals (RFP) for the supply of insulin pumps, consumables and CGMs. As a result of the RFP, Pharmac has entered into provisional agreements with preferred suppliers, including Abbott to fund a range of devices.
From 1 July 2024, FreeStyle Libre 2 is proposed to be subsidised for all people living with type 1 diabetes in New Zealand!
From 1 October 2024, an additional Abbott brand of CGM is also proposed to be subsidised that will be compatible with funded insulin pumps and can be used to create an automated insulin delivery system.
What more can you do before 1 July 2024
Pharmac has called for public consultation into the funding proposal, including how it should be rolled out into the health system. The public consultation will continue until 4pm, Friday 26 April, and this is your opportunity to have input into how the proposal is rolled out.
Please note - the public consultation has now been completed. Please keep checking back here or click the button below to register for updates on its outcome.
Keep in touch with important updates
In the leadup to the anticipated start date for access to CGM funding (1 July 2024), you can find out the latest news by registering your interest online with Mediray - including updates on the proposed FreeStyle Libre 2 CGM subsidy and the process. Please click the button below to register.
The FreeStyle Libre Flash Glucose Monitoring System and the FreeStyle Libre 2 Flash Glucose Monitoring system is indicated for measuring interstitial fluid glucose levels in people (aged 4 and older) with insulin-dependent diabetes. The indication for children (age 4 – 17) is limited to those who are supervised by a caregiver who is at least 18 years of age. Always read the instructions for use. The system must not be used with automated insulin dosing (AID) systems, including closed-loop and insulin suspend systems. The sensor must be removed prior to Magnetic Resonance Imaging (MRI).
The sensor housing, FreeStyle, Libre and related brand marks are marks of Abbott. Information contained herein is for distribution outside of the USA only. ADC-91615 V2.0